These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24887383)

  • 21. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
    Radhi M; Rumelhart S; Tatman D; Goldman F
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ transplant recipients, report of five cases and review of the literature.
    Miloh T; Arnon R; Roman E; Hurlet A; Kerkar N; Wistinghausen B
    Pediatr Transplant; 2011 Dec; 15(8):870-8. PubMed ID: 22112003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
    Olfat M; Silverman ED; Levy DM
    Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.
    Solomon SR; Sizemore CA; Ridgeway M; Zhang X; Smith J; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1576-82. PubMed ID: 25985915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults.
    Provan D; Butler T; Evangelista ML; Amadori S; Newland AC; Stasi R
    Haematologica; 2007 Dec; 92(12):1695-8. PubMed ID: 18055995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
    Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
    Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with β-thalassaemia.
    Oikonomopoulou C; Paisiou A; Komitopoulou A; Ioannidou ED; Kaisari A; Tzannou I; Mpourazani E; Vessalas G; Peristeri I; Kitra-Roussou V; Goussetis E
    Br J Haematol; 2021 Mar; 192(5):e127-e129. PubMed ID: 33522599
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel immunomodulatory treatment involving mycophenolate mofetil and corticosteroids for pediatric autoimmune cytopenias.
    Panigrahi A; Clark A; Myers J; Raj A
    Pediatr Blood Cancer; 2017 Feb; 64(2):287-293. PubMed ID: 27615037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases.
    Dufour JF; Pradat P; Ruivard M; Hot A; Dumontet C; Broussolle C; Trepo C; Sève P
    Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):245-53. PubMed ID: 19279468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
    Peñalver FJ; Alvarez-Larrán A; Díez-Martin JL; Gallur L; Jarque I; Caballero D; Díaz-Mediavilla J; Bustelos R; Fernández-Aceñero MJ; Cabrera JR;
    Ann Hematol; 2010 Nov; 89(11):1073-80. PubMed ID: 20526716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenence rituximab following induction in autoimmune cytopenias.
    Rai MP; Lee EJ; Bussel JB
    Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects.
    Koo J; Giller RH; Quinones R; McKinney CM; Verneris MR; Knight-Perry J
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28591. PubMed ID: 32658382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune hemolytic anemia--selected topics.
    Hoffman PC
    Hematology Am Soc Hematol Educ Program; 2009; ():80-6. PubMed ID: 20008185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment.
    Neely J; von Scheven E
    Curr Opin Rheumatol; 2018 Sep; 30(5):498-505. PubMed ID: 29979258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
    Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH).
    González-Vicent M; Sanz J; Fuster JL; Cid J; de Heredia CD; Morillo D; Fernández JM; Pascual A; Badell I; Serrano D; Fox L; de la Serna J; Benito A; Couselo JM; Molina B; Díaz MÁ; Sanz MÁ
    Transfus Med Rev; 2018 Mar; ():. PubMed ID: 29573905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab administration within 6 months of T cell-depleted allogeneic SCT is associated with prolonged life-threatening cytopenias.
    McIver Z; Stephens N; Grim A; Barrett AJ
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1549-56. PubMed ID: 20580848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.
    Sanz J; Montoro J; Solano C; Valcárcel D; Sampol A; Ferrá C; Parody R; Lorenzo I; Montesinos P; Ortí G; Hernández-Boluda JC; Balaguer-Roselló A; Guerreiro M; Carretero C; Sanz GF; Sanz MA; Piñana JL
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):358-366. PubMed ID: 31655119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies.
    Barcellini W; Zaja F; Zaninoni A; Imperiali FG; Battista ML; Di Bona E; Fattizzo B; Consonni D; Cortelezzi A; Fanin R; Zanella A
    Blood; 2012 Apr; 119(16):3691-7. PubMed ID: 22267606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.